185 related articles for article (PubMed ID: 15591953)
1. Enzyme-linked immunosorbent spot assay for donor-reactive interferon-gamma-producing cells identifies T-cell presensitization and correlates with graft function at 6 and 12 months in renal-transplant recipients.
Nickel P; Presber F; Bold G; Biti D; Schönemann C; Tullius SG; Volk HD; Reinke P
Transplantation; 2004 Dec; 78(11):1640-6. PubMed ID: 15591953
[TBL] [Abstract][Full Text] [Related]
2. Preferential benefit of antibody induction therapy in kidney recipients with high pretransplant frequencies of donor-reactive interferon-gamma enzyme-linked immunosorbent spots.
Augustine JJ; Poggio ED; Heeger PS; Hricik DE
Transplantation; 2008 Aug; 86(4):529-34. PubMed ID: 18724221
[TBL] [Abstract][Full Text] [Related]
3. Pretransplant donor-specific interferon-gamma ELISPOT assay predicts acute rejection episodes in renal transplant recipients.
Kim SH; Oh EJ; Kim MJ; Park YJ; Han K; Yang HJ; Kim JY; Choi BS; Yang CW; Kim YS; Bang BK
Transplant Proc; 2007 Dec; 39(10):3057-60. PubMed ID: 18089321
[TBL] [Abstract][Full Text] [Related]
4. Modified ELISPOT technique--highly significant inverse correlation of post-Tx donor-reactive IFNgamma-producing cell frequencies with 6 and 12 months graft function in kidney transplant recipients.
Näther BJ; Nickel P; Bold G; Presber F; Schönemann C; Pratschke J; Volk HD; Reinke P
Transpl Immunol; 2006 Nov; 16(3-4):232-7. PubMed ID: 17138059
[TBL] [Abstract][Full Text] [Related]
5. Posttransplant peripheral blood donor-specific interferon-γ enzyme-linked immune spot assay differentiates risk of subclinical rejection and de novo donor-specific alloantibodies in kidney transplant recipients.
Crespo E; Cravedi P; Martorell J; Luque S; Melilli E; Cruzado JM; Jarque M; Meneghini M; Manonelles A; Donadei C; Lloberas N; Gomà M; Grinyó JM; Heeger P; Bestard O
Kidney Int; 2017 Jul; 92(1):201-213. PubMed ID: 28274484
[TBL] [Abstract][Full Text] [Related]
6. Enzyme-linked immunosorbent spot assay analysis of peripheral blood lymphocyte reactivity to donor HLA-DR peptides: potential novel assay for prediction of outcomes for renal transplant recipients.
Najafian N; Salama AD; Fedoseyeva EV; Benichou G; Sayegh MH
J Am Soc Nephrol; 2002 Jan; 13(1):252-259. PubMed ID: 11752045
[TBL] [Abstract][Full Text] [Related]
7. Impact of preformed T-cell alloreactivity by means of donor-specific and panel of reactive T cells (PRT) ELISPOT in kidney transplantation.
Gandolfini I; Crespo E; Baweja M; Jarque M; Donadei C; Luque S; Montero N; Allesina A; Perin L; Maggiore U; Cravedi P; Bestard O
PLoS One; 2018; 13(7):e0200696. PubMed ID: 30059561
[TBL] [Abstract][Full Text] [Related]
8. Pretransplant frequency of donor-specific, IFN-gamma-producing lymphocytes is a manifestation of immunologic memory and correlates with the risk of posttransplant rejection episodes.
Heeger PS; Greenspan NS; Kuhlenschmidt S; Dejelo C; Hricik DE; Schulak JA; Tary-Lehmann M
J Immunol; 1999 Aug; 163(4):2267-75. PubMed ID: 10438971
[TBL] [Abstract][Full Text] [Related]
9. High levels of CMV-IE-1-specific memory T cells are associated with less alloimmunity and improved renal allograft function.
Nickel P; Bold G; Presber F; Biti D; Babel N; Kreutzer S; Pratschke J; Schönemann C; Kern F; Volk HD; Reinke P
Transpl Immunol; 2009 Mar; 20(4):238-42. PubMed ID: 19032982
[TBL] [Abstract][Full Text] [Related]
10. Enzyme linked immunosorbent spot (ELISPOT) assay for interferon-gamma independently predicts renal function in kidney transplant recipients.
Hricik DE; Rodriguez V; Riley J; Bryan K; Tary-Lehmann M; Greenspan N; Dejelo C; Schulak JA; Heeger PS
Am J Transplant; 2003 Jul; 3(7):878-84. PubMed ID: 12814480
[TBL] [Abstract][Full Text] [Related]
11. Pre-transplant donor-specific Interferon-gamma-producing cells and acute rejection of the kidney allograft.
Slavcev A; Rybakova K; Svobodova E; Slatinska J; Honsova E; Skibova J; Viklicky O; Striz I
Transpl Immunol; 2015 Oct; 33(2):63-8. PubMed ID: 26254561
[TBL] [Abstract][Full Text] [Related]
12. Pretransplant cellular alloimmunity as assessed by a panel of reactive T cells assay correlates with acute renal graft rejection.
Poggio ED; Augustine JJ; Clemente M; Danzig JM; Volokh N; Zand MS; Hricik DE; Heeger PS
Transplantation; 2007 Apr; 83(7):847-52. PubMed ID: 17460554
[TBL] [Abstract][Full Text] [Related]
13. Enzyme-Linked Immunosorbent Spot (ELISpot) monitoring of cytokine-producing cells for the prediction of acute rejection in renal transplant patients.
Mohammadi F; Solgi G; Tajik M; Ahmadpoor P; Nikoeinejad H; Einollahi B; Nazari B; Lessan-Pezeshki M; Amirzargar A
Eur Cytokine Netw; 2017 Sep; 28(3):93-101. PubMed ID: 29187340
[TBL] [Abstract][Full Text] [Related]
14. Analysis of Biomarkers Within the Initial 2 Years Posttransplant and 5-Year Kidney Transplant Outcomes: Results From Clinical Trials in Organ Transplantation-17.
Faddoul G; Nadkarni GN; Bridges ND; Goebel J; Hricik DE; Formica R; Menon MC; Morrison Y; Murphy B; Newell K; Nickerson P; Poggio ED; Rush D; Heeger PS;
Transplantation; 2018 Apr; 102(4):673-680. PubMed ID: 29189482
[TBL] [Abstract][Full Text] [Related]
15. Monitoring of cellular immunity by interferon-gamma enzyme-linked immunosorbent spot assay in kidney allograft recipients: preliminary results of a longitudinal study.
Bellisola G; Tridente G; Nacchia F; Fior F; Boschiero L
Transplant Proc; 2006 May; 38(4):1014-7. PubMed ID: 16757248
[TBL] [Abstract][Full Text] [Related]
16. Transplantectomy is associated with presensitization with donor-reactive T cells and graft failure after kidney retransplantation: a cohort study.
Schachtner T; Otto NM; Stein M; Reinke P
Nephrol Dial Transplant; 2018 May; 33(5):889-896. PubMed ID: 29401311
[TBL] [Abstract][Full Text] [Related]
17. Interferon Gamma ELISPOT Testing as a Risk-Stratifying Biomarker for Kidney Transplant Injury: Results From the CTOT-01 Multicenter Study.
Hricik DE; Augustine J; Nickerson P; Formica RN; Poggio ED; Rush D; Newell KA; Goebel J; Gibson IW; Fairchild RL; Spain K; Iklé D; Bridges ND; Heeger PS;
Am J Transplant; 2015 Dec; 15(12):3166-73. PubMed ID: 26226830
[TBL] [Abstract][Full Text] [Related]
18. Pretransplant donor-specific and non-specific immune parameters associated with early acute rejection.
Reinsmoen NL; Cornett KM; Kloehn R; Burnette AD; McHugh L; Flewellen BK; Matas A; Savik K
Transplantation; 2008 Feb; 85(3):462-70. PubMed ID: 18301338
[TBL] [Abstract][Full Text] [Related]
19. Enzyme-linked immunosorbent assay spot detection of interferon-gamma and interleukin 5-producing cells as a predictive marker for renal allograft failure.
Tary-Lehmann M; Hricik DE; Justice AC; Potter NS; Heeger PS
Transplantation; 1998 Jul; 66(2):219-24. PubMed ID: 9701268
[TBL] [Abstract][Full Text] [Related]
20. Preformed donor-reactive T cells that persist after ABO desensitization predict severe T cell-mediated rejection after living donor kidney transplantation - a retrospective study.
Schachtner T; Stein M; Otto NM; Reinke P
Transpl Int; 2020 Mar; 33(3):288-297. PubMed ID: 31696547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
